Ryoichi Fujiwara Selected Research

UGT1A1 enzyme

11/2015	Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.
11/2013	Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia.
10/2013	Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryoichi Fujiwara Research Topics

Disease

5	Hyperbilirubinemia 01/2018 - 03/2010
5	Neonatal Hyperbilirubinemia 10/2017 - 10/2013
3	Seizures (Absence Seizure) 01/2020 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 06/2016
2	Kernicterus 01/2018 - 10/2017
2	Chemical and Drug Induced Liver Injury 11/2016 - 01/2016
2	Neonatal Jaundice 09/2014 - 10/2013
2	Skin Diseases (Skin Disease) 06/2014 - 10/2013
2	Jaundice (Icterus) 11/2013 - 01/2012
1	Wound Infection (Wound Infections) 11/2021
1	Wounds and Injuries (Trauma) 11/2021
1	Drug-Related Side Effects and Adverse Reactions 02/2018
1	Hallucinations (Hallucination) 01/2018
1	Supraventricular Tachycardia 01/2018
1	Chest Pain (Chest Pains) 01/2018
1	Hypothermia 01/2018
1	Syncope (Fainting) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Crigler-Najjar Syndrome 10/2017
1	Liddle Syndrome 08/2017
1	Leukemia 10/2016
1	Liver Diseases (Liver Disease) 10/2016
1	Hepatocellular Carcinoma (Hepatoma) 10/2016
1	Neurodevelopmental Disorders 01/2016
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2013
1	Gingival Hyperplasia 09/2007

Drug/Important Bio-Agent (IBA)

9	BilirubinIBA 01/2018 - 03/2010
4	Pharmaceutical PreparationsIBA 11/2021 - 10/2013
4	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2018 - 03/2010
3	CannabinoidsIBA 01/2020 - 01/2018
3	EnzymesIBA 01/2018 - 06/2014
3	UGT1A1 enzymeIBA 11/2015 - 10/2013
2	AntioxidantsIBA 10/2017 - 01/2012
2	VildagliptinIBA 10/2016 - 06/2016
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2016 - 09/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	GelatinIBA 11/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 11/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 11/2021
1	HydrogelsIBA 11/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	Designer DrugsIBA 01/2020
1	LigandsIBA 01/2020
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 01/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	IncretinsIBA 01/2018
1	UridineIBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2018
1	zinc protoporphyrinIBA 10/2017
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2017
1	protopanaxadiolIBA 08/2017
1	isoliquiritigenin (GU 17)IBA 08/2017
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Messenger RNA (mRNA)IBA 10/2016
1	trovafloxacinIBA 01/2016
1	Chemokine CXCL2IBA 01/2016
1	CytokinesIBA 01/2016
1	ArsenicIBA 01/2016
1	CadmiumIBA 01/2016
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2014
1	SolutionsIBA 09/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2013
1	Constitutive Androstane ReceptorIBA 01/2012
1	Uridine Diphosphate (UDP)IBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	Pregnane X ReceptorIBA 01/2012

Therapy/Procedure

1	Therapeutics 01/2018
1	Phototherapy (Light Therapy) 11/2013